| The Latest on Changes in CIRM's Biotech Loan Program February 2, 2010 at 7:43 PM |
| CIRM today reported another change in what is to be expected concerning alterations in the $500 million biotech loan program at tomorrow's and Thursday's meetings of its board of directors. In an email, Don Gibbons, CIRM's chief communications officer, said,"There is a bit of change again in the agenda. We decided that we needed the loan term guidelines for the Early Translational RFA and that | |
| Advisory February 2, 2010 at 6:43 PM |
| The link in the "Fecundity" item today was faulty. It has now been fixed. | |
| Fecundity, Stem Cells and the Dark Side of Prop. 71 February 2, 2010 at 7:30 AM |
| Los Angeles Times columnist Michael Hiltzik has provided a bit of a filip to his look Monday at the California stem cell agency.It came in the form of an entry in his blog entitled "Of stem cells and administrative arrogance."Among other things, he said Prop. 71, which created California's $3 billion research effort, was "too specific about how the program would be managed and how it would spend | | |
No comments:
Post a Comment